Both in Biotechnology
IRulya Therapeutics vs Fennec Pharmaceuticals
Over the past year IRLA returned +22.8% and FENC returned +1.7%; their daily moves had a correlation of 0.46.
IRLA +22.8% FENC +1.7%Growth of $1, one year, split-adjusted
| Metric | IRLA | FENC |
|---|---|---|
| Price | $39.78 | $10.90 |
| Market cap | $431.3M | $382.2M |
| Today | +3.78% | +2.44% |
| 1 month | +32.6% | +9.2% |
| 6 months | — | +18.0% |
| Year to date | — | +41.6% |
| 1 year | — | +37.6% |
| Revenue growth (YoY) | — | +85.2% |
| Gross margin | — | 96.0% |
| Net margin | — | 11.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 6.5× |
| Net cash | — | $41.2M |
| Dividend yield | — | — |
| Volatility (60d) | — | 51.6% |
| Short % of float | 14.2% | 2.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).